Results 261 to 270 of about 1,261,156 (366)

CARDIOVASCULAR EVENTS ASSOCIATED WITH COMBINATION MEK/BRAF INHIBITORS (ANALYSIS OF THE FDA ADVERSE EVENTS REPORTING SYSTEM)

, 2020
Avirup Guha, Michael G. Fradley, Daniel J. Lenihan, Prantesh Jain, Guilherme José Pimentel Lopes de Oliveira, Sadeer Al‐Kindi   +5 more
openalex   +1 more source

Radiation‐Resistant Bacteria Deinococcus radiodurans‐Derived Extracellular Vesicles as Potential Radioprotectors

Advanced Healthcare Materials, EarlyView.
Deinococcus radiodurans‐derived extracellular vesicles (R1‐EVs) provide radioprotection against total‐body irradiation‐induced acute radiation syndrome in mice. R1‐EVs mitigate oxidative damage by scavenging free radicals, promoting intestinal repair, enhancing hematopoietic function, and modulating immune responses. This study highlights the potential
Jeong Moo Han, Godfrey Mwiti, Seo‐Joon Yeom, Jaeyoon Lim, Woo Sik Kim, Sangyong Lim, Seung‐Taik Lim, Eui‐Baek Byun   +7 more
wiley   +1 more source

Exploring Connections Between Weight-Loss Medications and Thyroid Cancer: A Look at the FDA Adverse Event Reporting System Database. [PDF]

Endocrinol Diabetes Metab
Abi Zeid Daou C, Aboul Hosn O, Ghzayel L, Mourad M.   +3 more
europepmc   +1 more source

Supercritical Fluid‐Processed Multifunctional Hybrid Decellularized Extracellular Matrix with Chitosan Hydrogel for Improving Photoaged Dermis Microenvironment

Advanced Healthcare Materials, EarlyView.
These findings advance tissue repair by offering a multifunctional filler that improves large‐scale volume retention, elasticity, and support for vascularized tissue growth. The decellularized extracellular matrix (dECM)‐based material provides low injection force and minimizes swelling, ensuring sustained volume. Combining CMC with supercritical fluid‐
Seol‐Ha Jeong, Jae Jun Kang, Ki‐Myo Kim, Mi hyun lee, Misun Cha, Su Hee Kim, Ji‐Ung Park   +6 more
wiley   +1 more source

A real-world disproportionality analysis of ripretinib data mining of the public version of FDA adverse event reporting system. [PDF]

Front Pharmacol
Feng Y, Fa X, Wang Y, Zhang T, Sun X, Li F.   +5 more
europepmc   +1 more source

Committee for Academic Affairs JSSHP Research Award 2019 Basic Research Screening of an Angiotensin II Receptor Blocker with Low Adverse Fetal Effect using Adverse Event Reporting System and Mechanism of the Low Placental Transfer

, 2020
Tomohiro Nishimura, Yu Ishikawa, Saki Noguchi, Masatoshi Tomi   +3 more
openalex   +2 more sources

Universal Hydrogel Carrier Enhances Bone Graft Success: Preclinical and Clinical Evaluation

Advanced Healthcare Materials, EarlyView.
TX hydrogel improves the delivery of different types of particulate bone grafts, maintaining them at the implantation sites, and resulting in favorable bone regenerative outcomes. Abstract Orthopedic, maxillofacial, and complex dentoalveolar bone grafting procedures that require donor‐site bone harvesting can be associated with post‐surgical ...
Dax Calder, Farshad Oveissi, Simin Maleknia, Tom Huang, Bernard Koong, Terence Abrams, Andrew Oar, Wojciech Chrzanowski, Fariba Dehghani, Ali Fathi   +9 more
wiley   +1 more source

Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA's adverse event reporting system database. [PDF]

Front Pharmacol
Li Q, Shan W, Wu S.
europepmc   +1 more source

Bioprinting Perfusable and Vascularized Skeletal Muscle Flaps for the Treatment of Volumetric Muscle Loss

Advanced Healthcare Materials, EarlyView.
Volumetric muscle loss (VML) due to trauma or surgery, often leads to physical impairments. Traditional treatments rely on autologous flaps, limited by muscle availability often leading to donor site morbidity. This study presents multimodal bioprinting as an innovative approach for fabricating vascularized muscle flaps with 3D‐printed macrovessels ...
Eliana O. Fischer, Anna Tsukerman, Majd Machour, Margarita Shuhmaher, Asaf Silverstein, Maya Yaakov, Orit Bar‐Am, Lior Debbi, Shulamit Levenberg   +8 more
wiley   +1 more source

A disproportionality analysis of real-world events from the FDA Adverse Event Reporting System (FAERS) for Atezolizumab. [PDF]

BMC Pharmacol Toxicol
Li Z, Zhu N, Liu Y, Yu Y, Wang T, Zou C, Wang S, Ou X.   +7 more
europepmc   +1 more source